NCT Number: NCT00946491
To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers
To demonstrate the relative bioequivalency of generic Haloperidol tablets versus Haldol in normal volunteers.
Looking for future studies?
Notify MeKey information
Conditions
Age range
35 year–55 year
Sex eligibility
Male
Study type
Interventional
Phase
Phase 1
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.
Exclusion criteria
- Positive test results for HIV or hepatitis B or C.
- Treatment for drug or alcohol dependence.
Treatment and study plan
Haldol 10 mg Tablets (McNeil Pharmaceuticals)
DrugPrimary outcomes
-
Bioequivalence based on AUC and Cmax
Time frame: 17 days
Sponsors and collaborators
Lead sponsor
Sandoz
Industry
Registry information
Official study title
An Open-Label, Single-Dose, Crossover Study to Determine the Bioequivalency of Generic Haloperidol Tablets vs. Haldol in Normal Volunteers.
Important dates
- Study start
- 1987
- Primary completion
- 1987
- Study completion
- 1987
- First posted
- Jul 27, 2009
- Registry last updated
- Mar 28, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Tele-group Cognitive Behavioural Family Intervention for People With Schizophrenia and Their Families (Feasibility tgCBFI)
NCT05808244
Mental Disorders, Psychosis
Kowloon, Hong Kong
View Trial DetailsAcute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care
NCT07364825
Anxiety, Anxiety Disorders
Belmont, Massachusetts, United States
View Trial DetailsMulti-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis
NCT04004416
Bipolar Disorder, Bipolar and Related Disorders
Ann Arbor, Michigan, United States
View Trial DetailsStrengthening Care in Collaboration With People With Lived Experience of Psychosis in Uganda
NCT05863572
Mental Disorders, Psychosis
Kampala, Uganda
View Trial Details